Criterium Inc.
Contract research organization providing end-to-end clinical trial services, integrated eClinical systems, centralized translational research consortia support, real-world data capture, and data management. Offers hybrid and remote trial operations with centralized workflows and real-time reporting for oncology and other therapeutic areas.
Industries
Nr. of Employees
medium (51-250)
Products
IVR/IWR
Interactive Voice Response (IVR), Web-Board Reporting (IWR/IRT), and electronic Patient Reported Outcomes (ePRO) systems that interface seamlessly with EDC for comprehensive clinical study management, data collection, and real-time reporting.
Full Service Research
Comprehensive clinical research services spanning Phase I through Phase IV, registration, launch, and post-marketing studies.
Academic Thoracic Oncology Medical Investigators Consortium
An innovative and focused full-service clinical research model and consortium created to enhance the state of care for thoracic and lung cancer patients by expediting clinical trials and identifying new targeted drugs.
GI Cancer Consortium
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Academic GI Cancer Consortium (AGICC)
An innovative research model bringing together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal cancers.
Breast Cancer Consortium
An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
IVR/IWR
Interactive Voice Response (IVR), Web-Board Reporting (IWR/IRT), and electronic Patient Reported Outcomes (ePRO) systems that interface seamlessly with EDC for comprehensive clinical study management, data collection, and real-time reporting.
Full Service Research
Comprehensive clinical research services spanning Phase I through Phase IV, registration, launch, and post-marketing studies.
Academic Thoracic Oncology Medical Investigators Consortium
An innovative and focused full-service clinical research model and consortium created to enhance the state of care for thoracic and lung cancer patients by expediting clinical trials and identifying new targeted drugs.
GI Cancer Consortium
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Academic GI Cancer Consortium (AGICC)
An innovative research model bringing together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal cancers.
Breast Cancer Consortium
An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
Services
Operational delivery across study phases including monitoring, site management, regulatory support, safety reporting and study closeout.
Design, deployment and hosting of integrated IVR/IWR, EDC and ePRO solutions for registration, randomization, electronic diaries and real-time reporting.
Operational coordination, site standardization and centralized contract/budget management for multi-institution translational research consortia with emphasis on oncology indications.
Operational delivery across study phases including monitoring, site management, regulatory support, safety reporting and study closeout.
Design, deployment and hosting of integrated IVR/IWR, EDC and ePRO solutions for registration, randomization, electronic diaries and real-time reporting.
Operational coordination, site standardization and centralized contract/budget management for multi-institution translational research consortia with emphasis on oncology indications.
Expertise Areas
- Clinical trial management
- eClinical systems integration
- Interactive response systems and eCOA
- Translational research consortia coordination
Key Technologies
- Interactive voice response (IVR)
- Web-based interactive response (IWR)
- Electronic data capture (EDC)
- ePRO / eCOA platforms
News & Updates
Summary of advances in breast cancer diagnostics and treatments, including imaging, biomarkers and targeted therapies.
Overview of notable trials and research areas expected to advance in 2026, including targeted therapies and studies for long COVID and cardiovascular disease.
Summary of recent research directions in Parkinson’s disease, covering biomarkers, genetic targets and adaptive neuromodulation.
Discussion of advances in genetic research, gene editing, RNA-based therapies and AI-supported genomic analysis for rare diseases.
Outline of recent cardiovascular research including metabolic therapies, AI-enabled ECG models and minimally invasive interventions.
Review of diagnostic and therapeutic advances in lung cancer, including non-invasive diagnostics, AI in imaging and genomics, and emerging therapeutics such as ADCs, immunotherapy and mRNA approaches.
Summary of advances in breast cancer diagnostics and treatments, including imaging, biomarkers and targeted therapies.
Overview of notable trials and research areas expected to advance in 2026, including targeted therapies and studies for long COVID and cardiovascular disease.
Summary of recent research directions in Parkinson’s disease, covering biomarkers, genetic targets and adaptive neuromodulation.
Discussion of advances in genetic research, gene editing, RNA-based therapies and AI-supported genomic analysis for rare diseases.
Outline of recent cardiovascular research including metabolic therapies, AI-enabled ECG models and minimally invasive interventions.
Review of diagnostic and therapeutic advances in lung cancer, including non-invasive diagnostics, AI in imaging and genomics, and emerging therapeutics such as ADCs, immunotherapy and mRNA approaches.